Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 27, 2018 - The FDA announced the discontinuation of Endo’s Sumavel DosePro (sumatriptan) 6 mg/0.5 mL injection.
Download PDF
Return to publications
